aluates Reports

$ 0.0

Automative

Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-10W18182

BUY CHAPTERS

Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Research Report 2024

Code: QYRE-Auto-10W18182

Report

August 2024

Pages:70

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vendors

GlaxoSmithKline PLC

GlaxoSmithKline

Merck

Kangtai Bio

Measles, Mumps, Rubella, and Varicella Combined Vaccine Market

The global Measles, Mumps, Rubella, and Varicella Combined Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Measles, Mumps, Rubella, and Varicella Combined Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Measles, Mumps, Rubella, and Varicella Combined Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Measles, Mumps, Rubella, and Varicella Combined Vaccine include Merck & Co, GlaxoSmithKline, Kangtai Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Measles, Mumps, Rubella, and Varicella Combined Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles, Mumps, Rubella, and Varicella Combined Vaccine.

The Measles, Mumps, Rubella, and Varicella Combined Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Measles, Mumps, Rubella, and Varicella Combined Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Measles, Mumps, Rubella, and Varicella Combined Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Report

Report Metric	Details
Report Name	Measles, Mumps, Rubella, and Varicella Combined Vaccine Market
Segment by Type	Live Attenuated Vaccine Inactivated Vaccine
Segment by Application	Hospital Centers for Disease Control and Prevention Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & Co, GlaxoSmithKline, Kangtai Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles, Mumps, Rubella, and Varicella Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles, Mumps, Rubella, and Varicella Combined Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Measles, Mumps, Rubella, and Varicella Combined Vaccine Market report?

Ans: The main players in the Measles, Mumps, Rubella, and Varicella Combined Vaccine Market are Merck & Co, GlaxoSmithKline, Kangtai Bio

What are the Application segmentation covered in the Measles, Mumps, Rubella, and Varicella Combined Vaccine Market report?

Ans: The Applications covered in the Measles, Mumps, Rubella, and Varicella Combined Vaccine Market report are Hospital, Centers for Disease Control and Prevention, Others

What are the Type segmentation covered in the Measles, Mumps, Rubella, and Varicella Combined Vaccine Market report?

Ans: The Types covered in the Measles, Mumps, Rubella, and Varicella Combined Vaccine Market report are Live Attenuated Vaccine, Inactivated Vaccine

Recommended Reports

Pediatric & Viral Vaccines

Combination & Multivalent Vaccines

Innovative & Engineered Vaccines

1 Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Overview

1.1 Product Definition

1.2 Measles, Mumps, Rubella, and Varicella Combined Vaccine by Type

1.2.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Live Attenuated Vaccine

1.2.3 Inactivated Vaccine

1.3 Measles, Mumps, Rubella, and Varicella Combined Vaccine by Application

1.3.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Centers for Disease Control and Prevention

1.3.4 Others

1.4 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size Estimates and Forecasts

1.4.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue 2019-2030

1.4.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales 2019-2030

1.4.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Competition by Manufacturers

2.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Date of Enter into This Industry

2.8 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Competitive Situation and Trends

2.8.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Measles, Mumps, Rubella, and Varicella Combined Vaccine Players Market Share by Revenue

2.8.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Scenario by Region

3.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region: 2019-2030

3.2.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region: 2019-2024

3.2.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region: 2025-2030

3.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region: 2019-2030

3.3.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region: 2019-2024

3.3.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region: 2025-2030

3.4 North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Facts & Figures by Country

3.4.1 North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2030)

3.4.3 North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Facts & Figures by Country

3.5.1 Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2030)

3.5.3 Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Facts & Figures by Country

3.7.1 Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Type (2019-2030)

4.1.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Type (2019-2024)

4.1.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Type (2025-2030)

4.1.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Type (2019-2030)

4.2.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Type (2019-2024)

4.2.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Type (2025-2030)

4.2.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Application (2019-2030)

5.1.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Application (2019-2024)

5.1.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Application (2025-2030)

5.1.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Application (2019-2030)

5.2.1 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Application (2019-2024)

5.2.2 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Application (2025-2030)

5.2.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck & Co

6.1.1 Merck & Co Company Information

6.1.2 Merck & Co Description and Business Overview

6.1.3 Merck & Co Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck & Co Measles, Mumps, Rubella, and Varicella Combined Vaccine Product Portfolio

6.1.5 Merck & Co Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Company Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GlaxoSmithKline Measles, Mumps, Rubella, and Varicella Combined Vaccine Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Kangtai Bio

6.3.1 Kangtai Bio Company Information

6.3.2 Kangtai Bio Description and Business Overview

6.3.3 Kangtai Bio Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Kangtai Bio Measles, Mumps, Rubella, and Varicella Combined Vaccine Product Portfolio

6.3.5 Kangtai Bio Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Measles, Mumps, Rubella, and Varicella Combined Vaccine Industry Chain Analysis

7.2 Measles, Mumps, Rubella, and Varicella Combined Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Measles, Mumps, Rubella, and Varicella Combined Vaccine Production Mode & Process

7.4 Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales and Marketing

7.4.1 Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Channels

7.4.2 Measles, Mumps, Rubella, and Varicella Combined Vaccine Distributors

7.5 Measles, Mumps, Rubella, and Varicella Combined Vaccine Customers

8 Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Dynamics

8.1 Measles, Mumps, Rubella, and Varicella Combined Vaccine Industry Trends

8.2 Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Drivers

8.3 Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Challenges

8.4 Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Vendors

GlaxoSmithKline PLC

GlaxoSmithKline

Merck

Kangtai Bio

List of Tables

Table 1. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose) of Key Manufacturers (2019-2024)

Table 5. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Measles, Mumps, Rubella, and Varicella Combined Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Measles, Mumps, Rubella, and Varicella Combined Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles, Mumps, Rubella, and Varicella Combined Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region (2019-2024) & (Dose)

Table 18. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region (2025-2030) & (Dose)

Table 20. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2024) & (Dose)

Table 27. North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2025-2030) & (Dose)

Table 28. North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2024) & (Dose)

Table 32. Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2025-2030) & (Dose)

Table 33. Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region (2019-2024) & (Dose)

Table 37. Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Region (2025-2030) & (Dose)

Table 38. Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2024) & (Dose)

Table 42. Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2025-2030) & (Dose)

Table 43. Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2019-2024) & (Dose)

Table 47. Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales by Country (2025-2030) & (Dose)

Table 48. Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose) by Type (2019-2024)

Table 51. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose) by Type (2025-2030)

Table 52. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price (US$/Dose) by Type (2019-2024)

Table 59. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price (US$/Dose) by Type (2025-2030)

Table 60. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose) by Application (2019-2024)

Table 61. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose) by Application (2025-2030)

Table 62. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price (US$/Dose) by Application (2019-2024)

Table 69. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price (US$/Dose) by Application (2025-2030)

Table 70. Merck & Co Company Information

Table 71. Merck & Co Description and Business Overview

Table 72. Merck & Co Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 73. Merck & Co Measles, Mumps, Rubella, and Varicella Combined Vaccine Product

Table 74. Merck & Co Recent Developments/Updates

Table 75. GlaxoSmithKline Company Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 78. GlaxoSmithKline Measles, Mumps, Rubella, and Varicella Combined Vaccine Product

Table 79. GlaxoSmithKline Recent Developments/Updates

Table 80. Kangtai Bio Company Information

Table 81. Kangtai Bio Description and Business Overview

Table 82. Kangtai Bio Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 83. Kangtai Bio Measles, Mumps, Rubella, and Varicella Combined Vaccine Product

Table 84. Kangtai Bio Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Measles, Mumps, Rubella, and Varicella Combined Vaccine Distributors List

Table 88. Measles, Mumps, Rubella, and Varicella Combined Vaccine Customers List

Table 89. Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Trends

Table 90. Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Drivers

Table 91. Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Challenges

Table 92. Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Measles, Mumps, Rubella, and Varicella Combined Vaccine

Figure 2. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Share by Type: 2023 & 2030

Figure 4. Live Attenuated Vaccine Product Picture

Figure 5. Inactivated Vaccine Product Picture

Figure 6. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Centers for Disease Control and Prevention

Figure 10. Others

Figure 11. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size (2019-2030) & (US$ Million)

Figure 13. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales (2019-2030) & (Dose)

Figure 14. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Average Price (US$/Dose) & (2019-2030)

Figure 15. Measles, Mumps, Rubella, and Varicella Combined Vaccine Report Years Considered

Figure 16. Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Share by Manufacturers in 2023

Figure 17. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Measles, Mumps, Rubella, and Varicella Combined Vaccine Players: Market Share by Revenue in Measles, Mumps, Rubella, and Varicella Combined Vaccine in 2023

Figure 19. Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Country (2019-2030)

Figure 22. North America Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Country (2019-2030)

Figure 23. United States Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Country (2019-2030)

Figure 26. Europe Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Country (2019-2030)

Figure 27. Germany Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Region (2019-2030)

Figure 34. China Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Country (2019-2030)

Figure 42. Mexico Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Measles, Mumps, Rubella, and Varicella Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Measles, Mumps, Rubella, and Varicella Combined Vaccine by Type (2019-2030)

Figure 52. Global Revenue Market Share of Measles, Mumps, Rubella, and Varicella Combined Vaccine by Type (2019-2030)

Figure 53. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price (US$/Dose) by Type (2019-2030)

Figure 54. Global Sales Market Share of Measles, Mumps, Rubella, and Varicella Combined Vaccine by Application (2019-2030)

Figure 55. Global Revenue Market Share of Measles, Mumps, Rubella, and Varicella Combined Vaccine by Application (2019-2030)

Figure 56. Global Measles, Mumps, Rubella, and Varicella Combined Vaccine Price (US$/Dose) by Application (2019-2030)

Figure 57. Measles, Mumps, Rubella, and Varicella Combined Vaccine Value Chain

Figure 58. Measles, Mumps, Rubella, and Varicella Combined Vaccine Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Measles Mumps and Rubella MMR Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Measles and Rubella Vaccines Market Research Report 2025

Global Measles and Rubella MR Vaccine Market Research Report 2025

Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025

Global Combination Vaccine and Multivalent Vaccine Market Research Report 2024

Measles Mumps and Rubella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chickenpox Varicella Vaccine Market

Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Varicella Vaccine Market Research Report 2025

Global Multiple Vaccine Market Research Report 2024

Global Seasonal Vaccines Market Research Report 2024

Global Monkeypox Virus Vaccine Market Research Report 2024

Global Live Attenuated Measles Vaccine Market Research Report 2025

Global Measle Vaccine Market Research Report 2025

Global Veterinary Combination Vaccine and Multivalent Vaccine Market Research Report 2024

Global Vaccination Device Market Research Report 2024

Global Infant and Child Multiple Vaccine Market Research Report 2024

Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions